Prevest Denpro Ltd.

View in App
435.05 +1.55 ▲0.4%

01 December 2023, 04:01:00 PM
Volume: 13,600

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.prevestdenpro.com
Market Cap 523.39 Cr.
Enterprise Value(EV) 523.39 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 13.76 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 31.68 Trailing Twelve Months Ending 2023-09
Industry PE 62.55 Trailing Twelve Months Ending 2023-09
Book Value / Share 66.90 Trailing Twelve Months Ending 2023-09
Price to Book Value 6.52 Calculated using Price: 436.05
Dividend Yield 0.23 Period Ending 2023-03
No. of Shares Subscribed 1.20 Cr. 12,003,000 Shares
FaceValue 10
About Prevest Denpro Ltd.
The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Prevest Denpro Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Prevest Denpro Ltd. Performance

View details >>
1 Day
+0.36%
1 Week
-0.40%
1 Month
+0.37%
3 Month
-12.18%
6 Month
+2.36%
1 Year
+12.13%
2 Year
+91.53%
5 Year
10 Year

Prevest Denpro Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 29.72 34.02 39.13 38.13 29.07 24.19
Return on Capital Employed (%) 37.15 39.27 45.63 46.96 39.64 32.25
Return on Assets (%) 18.88 22.30 27.50 27.85 24.40 22.01

Prevest Denpro Ltd. Balance Sheet

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 7 10 15 23 57 73 80
Non Curr. Liab. 1 2 2 2 2 0 0
Curr. Liab. 3 3 4 7 5 5 5
Minority Int.
Equity & Liab. 12 15 21 31 64 79 86
Non Curr. Assets 4 5 6 7 11 24 26
Curr. Assets 7 10 16 24 53 54 59
Misc. Exp. not W/O
Total Assets 12 15 21 31 64 79 86

Prevest Denpro Ltd. Profit and Loss

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 17 19 23 28 38 50 53
Other Income 1 0 2 1 2 2 2
Total Income 18 20 25 30 40 52 55
Total Expenditure -14 -15 -18 -19 -23 -30 -33
PBIDT 4 4 7 10 17 22 22
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 -1 -1 -1
Taxation -1 -1 -1 -2 -4 -5 -5
Exceptional Items
PAT 2 3 5 7 12 16 17
Adjusted EPS 2 3 6 8 10 13 14

Prevest Denpro Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 2 3 5 9 7 11
Cash Fr. Inv. -1 -1 -1 -2 -4 -12
Cash Fr. Finan. 0 0 0 -1 23 -2
Net Change 1 2 4 6 26 -3
Cash & Cash Eqvt 4 6 10 16 42 39

Prevest Denpro Ltd. Shareholding Pattern

View details >>
8 Qtrs 2021-09 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 73.60 73.60 73.60 73.60 73.60 73.60 73.60 73.60
Public 26.40 26.40 26.40 26.40 26.40 26.40 26.40 26.40
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Prevest Denpro Ltd. Announcements

View details >>
Thu, 23 Nov 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015 please find enclosed press release.
Wed, 15 Nov 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of conference call with Investor held on November 09 2023.
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 read along with SEBI (Listing Obligation & Disclosure Requirements) (Second Amendment) Regulations 2021 please find audio recording of the Companys Earning Call held with the Investors/ Analysis on November 09 2023 to discuss Financial Results of the Company for the quarter and Half Year ended September 30 2023.

Prevest Denpro Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years
20 SMA Crossing 200 SMA From Above 20 SMA Crossing 200 SMA From Above

Prevest Denpro Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Prevest Denpro Ltd. FAQ's

What is Prevest Denpro share price?
Can I buy Prevest Denpro shares now?
What is the Dividend Yield of Prevest Denpro?
What is the Market Cap of Prevest Denpro?
What are the key metrics to analyse Prevest Denpro?
What is the 52 Week High and Low of Prevest Denpro?
What is the trend of Prevest Denpro share price?